Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Smoking Cessation for People Living With HIV/AIDS

NCT01965405
unknown

Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors

NCT02629926
completednot_applicable

The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure

NCT00505336

Clinical Trials (3)

Showing 3 of 3 trials
NCT01965405Not Applicable

Smoking Cessation for People Living With HIV/AIDS

Unknown
NCT02629926

Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors

Unknown
NCT00505336Not Applicable

The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3